Approaches to identifying genetic predictors of clinical outcome in rheumatoid arthritis

American Journal of PharmacoGenomics

Volumn 3, Issue 3, 2003, Pages 181-191

  Barton, Anne ^a   John, Sally ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COHORT ANALYSIS; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; GENE; GENETIC ANALYSIS; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; GENOTYPE; HEREDITY; HUMAN; LONGITUDINAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; NON MAJOR HISTOCOMPATIBILITY COMPLEX GENE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICS;

ANIMALS; ARTHRITIS, RHEUMATOID; CLINICAL TRIALS; GENETIC MARKERS; HUMANS; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME;

EID: 0038006961     PISSN: 11752203     EISSN: None     Source Type: Journal    
DOI: 10.2165/00129785-200303030-00004     Document Type: Review

References (73)

1. Seldin MF, Amos CI, Ward R, et al. The genetics revolution and the assault on rheumatoid arthritis. Arthritis Rheum 1999; 42: 1071-9
2. Brooks PM. The Heberden Oration 1997. Treatment of rheumatoid arthritis: from symptomatic relief to potential cure. Br J Rheumatol 1998; 37: 1265-71
3. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24
4. Jackson CG, Williams HJ. Disease-modifying antirheumatic drugs: using their clinical pharmacological effects as a guide to their selection. Drugs 1998; 56: 337-44
5. Brennan P, Harrison B, Barrett E, et al. A simple algorithm to predict the development of radiological erosions in patients with early rheumatoid arthritis: prospective cohort study. BMJ 1996 Aug 24; 313 (7055): 471-6
6. Drossaers-Bakker KW, Zwinderman AH, Vlieland TP, et al. Long-term outcome in rheumatoid arthritis: a simple algorithm of baseline parameters can predict radiographic damage, disability, and disease course at 12-year follow-up. Arthritis Rheum 2002; 47: 383-90
7. MacGregor AJ, Snieder H, Rigby AS, et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 2000; 43: 30-7
8. Thomson W, Pepper L, Bryton L. Absence of association between HLA DRB1*04 and rheumatoid arthritis in newly diagnosed cases from the community. Ann Rheum Dis 1993; 52: 539-41
9. Wilson SG, Bryant CD, Lariviere WR, et al. The heritability of antinociception: 11. Pharmacogenetic mediation of three over-the-counter analgesics in mice. J Pharmacol Exp Ther 2003 May; 305 (2): 755-64
10. Wilson SG, Smith SB, Chesler EJ, et al. The heritability of antinociception: common pharmacogenetic mediation of five neurochemically distinct analgesics. J Pharmacol Exp Ther 2003; 304: 547-59
11. Marra CA, Esdaile JM, Anis AH. Practical pharmacogenetics: the cost effectiveness of screening for thiopurine s-methyltransferase polymorphisms in patients with rheumatological conditions treated with azathioprine. J Rheumatol 2002; 29: 2507-12
12. Stastny P. HLA-D and Ia antigens in rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 1978; 21: S 139-43
13. Gregerson PK, Silver J, Winchester RJ. The shared epitope hypothesis. Arthritis Rheum 1987; 30: 1205-13
14. Ollier WE, Harrison B, Symmons D. What is the natural history of rheumatoid arthritis? Best Pract Res Clin Rheumatol 2001; 15: 27-48
15. Thomson W, Harrison B, Ollier B, et al. Quantifying the exact role of HLA-DRB1 alleles in susceptibility to inflammatory polyarthritis: results from a large, population-based study. Arthritis Rheum 1999; 42: 757-62
16. Fries JF, Wolfe F, Apple R, et al. HLA-DRB1 genotype associations in 793 white patients from a rheumatoid arthritis inception cohort: frequency, severity, and treatment bias. Arthritis Rheum 2002; 46: 2320-9
17. Buckner JH, Nepom GT. Genetics of rheumatoid arthritis: is there a scientific explanation for the human leukocyte antigen association? Curr Opin Rhcumatol 2002; 14: 254-9
18. Zanelli E, Gonzalez-Gay MA, David CS. Could HLA-DRB1 be the protective locus in rheumatoid arthritis? Immunol Today 1995; 16: 274-8
19. Taneja V, David CS. HLA transgenic mice as humanized mouse models of disease and immunity. J Clin Invest 1998; 101: 921-6
20. Ota M, Katsuyama Y, Kimura A, et al. A second susceptibility gene for developing rheumatoid arthritis in the human MHC is localised within a 70Kb interval telomeric of the TNF genes in the HLA class III region. Genomics 2001; 71: 263-70
21. Zanelli E, Jones G, Pascual M, et al. The telomeric part of the HLA region predisposes to rheumatoid arthritis independently of the class II loci. Hum Immunol 2001; 62: 75-84
22. Jawaheer D, Li W, Graham RR, et al. Dissecting the genetic complexity of the association between human leukocyte antigens and rheumatoid arthritis. Am J Hum Genet 2002; 71: 585-94
23. Zanelli E, Jones G, Pascual M, et al. The telomeric part of the HLA region predisposes to rheumatoid arthritis independently of the class II loci. Hum Immunol 2001; 62: 75-84
24. Cardon LR, Palmer LJ. Population stratification and spurious allelic association. Lancet 2003; 361: 598-604
25. Cvetkovic JT, Wallberg-Jonsson S, Stegmayr B, et al. Susceptibility for and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF-alpha, IL-1beta, and IL-1Ra genes. J Rheumatol 2002; 29: 212-9
26. Vinasco J, Beraun Y, Nieto A, et al. Polymorphism at the TNF loci in rheumatoid arthritis. Tissue Antigens 1997; 49: 74-8
27. Lacki JK, Moser R, Korczowska I, et al. TNF-alpha gene polymorphism does not affect the clinical and radiological outcome of rheumatoid arthritis. Rheumatol Int 2000; 19: 137-40
28. Seki N, Kamizono S, Yamada A, et al. Polymorphisms in the 5′-flanking region of tumor necrosis factor-alpha gene in patients with rheumatoid arthritis. Tissue Antigens 1999; 54: 194-7
29. Yen JH, Chen CJ, Tsai WC, et al. Tumor necrosis factor promoter polymorphisms in patients with rheumatoid arthritis in Taiwan. J Rheumatol 2001; 28: 1788-92
30. Brinkman BM, Huizinga TW, Kurban SS, et al. Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease? Br J Rhematol 1997; 36: 516-21
31. Kaijzel EL, van Krugten MV, Brinkman BM, et al. Functional analysis of a human tumor necrosis factor alpha (TNF-alpha) promoter polymorphism related to joint damage in rheumatoid arthritis. Mol Med 1998; 4: 724-33
32. Fabris M, Di PE, D'Elia A, et al. Tumor necrosis factor-alpha gene polymorphism in severe and mild-moderate rheumatoid arthritis. J Rhematol 2002; 29: 29-33
33. van Krugten MV, Huizinga TW, Kaijzel EL, et al. Association of the TNF +489 polymorphism with susceptibility and radiographic damage in rheumatoid arthritis. Genes Immun 1999; 1: 91-6
34. Gough A, Faint J, Salmon M, et al. Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome. Arthritis Rheum 1994; 37: 1166-70
35. MacGregor A, Ollier W, Thomson W, et al. HLA-DRB1*0401/0404 genotype and rheumatoid arthritis: increased association in men, young age at onset, and disease severity. J Rheumatol 1995; 22: 1032-6
36. Mattey DL, Hassell AB, Dawes PT, et al. Independent association of rheumatoid factor and the HLA-DRB1 shared epitope with radiographic outcome in rheumatoid arthritis. Arthritis Rheum 2001; 44: 1529-33
37. Mattey DL, Hutchinson D, Dawes PT, et al. Smoking and disease severity in rheumatoid arthritis: association with polymorphism at the glutathione S-transferase M1 locus. Arthritis Rheum 2002; 46: 640-6
38. Rodriguez MR, Gonzalez-Escribano MF, Aguilar F, et al. Association of NRAMP1 promoter gene polymorphism with the susceptibility and radiological severity of rheumatoid arthritis. Tissue Antigens 2002; 59: 311-5
39. Genevay S, Di Giovine FS, Perneger TV, et al. Association of interleukin-4 and interleukin-1B gene variants with Larsen score progression in rheumatoid arthritis. Arthritis Rheum 2002; 47: 303-9
40. Ip WK, Lau YL, Chan SY, et al. Mannose-binding lectin and rheumatoid arthritis in southern Chinese. Arthritis Rheum 2000; 43: 1679-87
41. Graudal NA, Madsen HO, Tarp U, et al. The association of variant mannose binding lectin genotypes with radiographic outcome in rheumatoid arthritis. Arthritis Rheum 2000; 43: 515-21
42. Crilly A, Maiden N, Capell HA, et al. Predictive value of interleukin 1 gene polymorphisms for surgery. Ann Rheum Dis 2000; 59: 695-9
43. Buchs N, Di Giovine FS, Silvestri T, et al. IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels. Genes Immun 2001; 2: 222-8
44. Cantagrel A, Navaux F, Loubet-Lescoulie P, et al. Interleukin-1B, interleukin-1 receptor antagonist, interleukin-4 and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum 1999; 42: 1093-100
45. Crilly A, Bartlett JM, White A, et al. Investigation of novel polymorphisms within the 3′ region of the IL-6 gene in patients with rheumatoid arthritis using Genescan analysis. Cytokine 2001; 13: 109-12
46. Pascual M, Nieto A, Mataran L, et al. IL-6 promoter polymorphisms in rheumatoid arthritis. Genes Immun 2000; 1: 338-40
47. Zeidler HK, Kvien TK, Hannonen P, et al. Progression of joint damage in early active severe rheumatoid arthritis during 18 months of treatment: comparison of low-dose cyclosporin and parenteral gold. Br J Rheumatol 1998; 37: 874-82
48. Zapico I, Coto E, Rodriguez A, et al. A DNA polymorphism at the alpha2-macroglobulin gene is associated with the severity of rheumatoid arthritis. J Rheumatol 2000; 27: 2308-11
49. Khani-Hanjani A, Lacaille D, Hoar D, et al. Association between dinucleotide repeat in non-coding region of interferon-gamma gene and susceptibility to, and severity of, rheumatoid arthritis. Lancet 2000; 356: 820-5
50. Constantin A, Navaux F, Lauwers-Cances V, et al. Interferon gamma gene polymorphism and susceptibility to, and severity of, rheumatoid arthritis. Lancet 2001; 358: 2051-2
51. Zapico I, Coto E, Rodriguez A, et al, CCR5 (chemokine rcceptor-5) DNA-polymorphism influences the severity of rheumatoid arthritis. Genes Immun 2000; 1: 288-9
52. Mattey DL, Hassell AB, Dawes PT, et al. Influence of polymorphism in the manganese superoxide dismutase locus on disease outcome in rheumatoid arthritis: evidence for interaction with glutathione S-transferase genes. Arthritis Rheum 2000; 43: 859-64
53. Constantin A, Lauwers-Cances V, Navaux F, et al. Stromelysin 1 (matrix metalloproteinase 3) and HLA-DRB1 gene polymorphisms: association with severity and progression of rheumatoid arthritis in a prospective study. Arthritis Rheum 2002; 46: 1754-62
54. Ollier WE. Role of interferon-gamma gene in rheumatoid arthritis? Lancet 2000; 356: 783-4
55. Pokorny V, McLean L, McQueen F, et al. Interferon-gamma microsatellite and rheumatoid arthritis. Lancet 2001; 358: 122-3
56. Vandenbroeck K, Goris A, Billiau A, et al. Interferon gamma gene in rheumatoid arthritis. Lancet 2000; 356: 2191-2
57. Johnson GC, Esposito L, Barratt BJ, et al. Haplotype tagging for the identification of common disease genes. Nat Genet 2001; 29: 233-7
58. Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin-6 (IL6) transcriptional regulation. J Biol Chem 2000; 275: 18138-44
59. Bukhari M, Lunt M, Harrison BJ, et al. Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis: results from the Norfolk Arthritis Register Study, a large inception cohort. Arthritis Rheum 2002; 46: 906-12
60. Dugowson CE, Nelson JL, Koepsell TD. Evaluation of the 1987 revised criteria for rheumatoid arthritis in a cohort of newly diagnosed female patients. Arthritis Rheum 1990; 33: 1042-6
61. Orces CH, Del RI, Abel MP, et al. The number of deformed joints as a surrogate measure of damage in rheumatoid arthritis. Arthritis Rheum 2002; 47: 67-72
62. van der Heijde DM. Radiographic imaging: the 'gold standard' for assessment of disease progression in rheumatoid arthritis. Rheumatology (Oxford) 2000; 39 Suppl. 1: 9-16
63. Sharp JT. Radiologic assessment as an outcome measure in rheumatoid arthritis. Arthritis Rheum 1989; 32: 221-9
64. Boini S, Guillemin F. Radiographic scoring methods as outcome measures in rheumatoid arthritis: properties and advantages. Ann Rheum Dis 2001; 60: 817-27
65. Wolfe F, Strand V. Radiography of rheumatoid arthritis in the time of increasing drug effectiveness. Curr Rheumatol Rep 2001; 3: 46-52
66. Barton A, Platt H, Salway FM, et al. Non-HLA genetic influences on outcome of inflammatory polyarthritis: pilot data using presence of erosions by 5 years as an outcome measure [abstract]. British Society for Rheumatology XX Annual General Meeting; 2003 Apr 1-4; Manchester. Rheumatology 2003; 42 Suppl. 1: 81
67. Clayton D, McKeigue PM. Epidemiological methods for studying genes and environmental factors in complex diseases, Lancet 2001; 358: 1356-60
68. Cordell HJ, Clayton DG, A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes. Am J Hum Genet 2002; 70: 124-41
69. Ritchie MD, Hahn LW, Moore JH, Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Genet Epidemiol 2003; 24: 150-7
70. Hahn LW, Ritchie MD, Moore JH, Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 2003; 19: 376-82
71. Roses AD. Genome-based pharmacogenetics and the pharmaceutical industry. Nat Rev Drug Discov 2002; 1: 541-9
72. Ma XJ, Salunga R, Tuggle JT, et al. Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci U S A 2003 May 13; 100 (10): 5974-9
73. Van Der Pouw Kraan TC, Van Gaalen FA, Huizinga TW, et al. Discovery of distinctive gene expression profiles in rheumatoid synovium using cDNA microarray technology: evidence for the existence of multiple pathways of tissue destruction and repair. Genes Immun 2003; 4: 187-96